The Zero Declaration: This was posted in July on the eve of the 19th International AIDS conference, and its call is still open — “to focus the world’s struggle against tuberculosis on achieving zero TB deaths, zero new TB infections, and zero suffering from TB.” You can sign on as an individual or as an […]
For anyone concerned about a pullback in funding for global AIDS programs, this commentary in The Lancet Infectious Diseases is a must read. It addresses the apparent wavering commitment of donor countries amid the economic downturn and touches on the unfolding debate about the merits of disease-specific initiatives, such as PEPFAR, versus efforts to efforts to […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]